CHMP Agenda, page-9

Regardless of which way you cut it with regards to the EMA’s CHMP everything seems to be going according to standard protocols the way I see it, I don’t see how this thing can’t go through. I’ve already pencilled in profits on this one. I’ve seen analyst expecting a target price of $0.55 following approval which is more than reasonable and have come up with a similar figure myself. You can’t say that you can find another stock out there with the amount of risk you’re exposed to if you buy at current prices with an expected return of ~ %100 in mere months, which is what this stock currently offers.







This is not intended as financial advice and should not be constructed as so.